Quelles stimulations pour quelles femmes : le syndrome des ovaires polykystiques (SOPK)-Reference-Cited by-同舟云学术

Quelles stimulations pour quelles femmes : le syndrome des ovaires polykystiques (SOPK)

Published:2017-11 Issue:11 Volume:45 Page:623-631
ISSN:2468-7189
Container-title:Gynécologie Obstétrique Fertilité & Sénologie
language:fr
Short-container-title:Gynécologie Obstétrique Fertilité & Sénologie

Author:

Merviel P.,Bouée S.,Ménard M.,Le Martelot M.-T.,Roche S.,Lelièvre C.,Chabaud J.-J.,Jacq C.,Drapier H.,Beauvillard D.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference71 articles.

1. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance;Balen;Hum Reprod Update,2016

2. Polycystic ovary syndrome;Franks;N Engl J Med,1995

3. Insuline resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome;Poretsky;Obstet Gynecol,1994

4. Rotterdam Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome;ESHRE/ASRM;Fertil Steril,2004

5. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM Sponsored 3rd PCOS Consensus Workshop Group;Fauser;Fertil Steril,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of myo-inositol in women with polycystic ovary syndrome in the application of auxiliary reproductive technologies;Meditsinskiy sovet = Medical Council;2022-10-07

2. Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies;Reproductive Health;2021-01-19

3. Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome;Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity;2020-08-08